'Drug-in-capsule' demand for trial material drives Juniper micro-dose investment
Juniper Pharmaceuticals has made a “significant capital investment” to expand its Xcelodose powder micro-dosing system to feed demand for Phase I study materials.
Archives for November 23, 2015
Cyprotex: Predictive toxicology tech will help pharma cut animal study spending
Cyprotex has expanded its toxicology offering with a new in silico technology it claims will reduce preclinical costs and cut the number of animal studies required.
API sourcing leads US Gov to label Carlsbad's Acyclovir tablets as made in Asia
US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.
Pfizer gets OK for $160bn Allergan acquisition
The boards of Pfizer and Allergan yesterday signed a $160bn merger that will create the world’s biggest pharmaceutical company.
Abcam buys AxioMx for antibody production technology
Abcam has acquired monoclonal antibody production specialist AxioMx in a deal worth up to $45m (€42m).
Strides Shasun restarts API production at fire struck plant
Strides Shasun has restarted some active pharmaceutical ingredient (API) production at a plant in Cuddalore, India after a fire last week.